AI-based prediction of depression symptomatology in first-episode psychosis patients: insights from the EUFEST and RAISE-ETP clinical trials.
Mena S. et al, (2025), Psychol Med, 55
Are we hallucinating or can psychedelic drugs modulate the immune system to control inflammation?
Qureshi O. et al, (2025), Br J Pharmacol
Current Position and Future Direction of Inflammation in Neuropsychiatric Disorders: A Review.
Upthegrove R. et al, (2025), JAMA Psychiatry
The electroencephalography protocol for the Accelerating Medicines Partnership® Schizophrenia Program: Reliability and stability of measures.
Mathalon DH. et al, (2025), Schizophrenia (Heidelb), 11
Digital health technologies in the accelerating medicines Partnership® Schizophrenia Program.
Wigman JTW. et al, (2025), Schizophrenia (Heidelb), 11
The Future of Immunotherapies for Mental Illness: A Precision Medicine Perspective.
Wittenberg GM. et al, (2025), Biol Psychiatry
Body fluid biomarkers and psychosis risk in The Accelerating Medicines Partnership® Schizophrenia Program: design considerations.
Perkins DO. et al, (2025), Schizophrenia (Heidelb), 11
Sample ascertainment and clinical outcome measures in the Accelerating Medicines Partnership® Schizophrenia Program.
Addington J. et al, (2025), Schizophrenia (Heidelb), 11
The MR neuroimaging protocol for the Accelerating Medicines Partnership® Schizophrenia Program.
Harms MP. et al, (2025), Schizophrenia (Heidelb), 11
Cognitive assessment in the Accelerating Medicines Partnership® Schizophrenia Program: harmonization priorities and strategies in a diverse international sample.
Allott K. et al, (2025), Schizophrenia (Heidelb), 11
MRI data sharing in psychosis: Key challenges and a new Open Access resource for researchers.
Evans SL. et al, (2025), Schizophr Res, 277, 185 - 187
A network approach exploring the effects of cognitive remediation on cognition, symptoms, and functioning in early psychosis
Watson AJ. et al, (2025), Psychological medicine, 55
Depressive and Negative Symptoms in the Early and Established Stages of Schizophrenia: Integrating Structural Brain Alterations, Cognitive Performance, and Plasma Interleukin 6 Levels
Corsi-Zuelli F. et al, (2025), Biological Psychiatry Global Open Science, 5
A realist evaluation of social care practitioners' experiences with and understanding of applied healthcare research
Birdi GK. et al, (2025), BRITISH JOURNAL OF SOCIAL WORK
An analysis on the role of glucagon-like peptide-1 receptor agonists in cognitive and mental health disorders
De Giorgi R. et al, (2025), Nature Mental Health
Brain and body energy metabolism and potential for treatment of psychiatric disorders
Andreazza AC. et al, (2025), NATURE MENTAL HEALTH, 3, 763 - 771
Current and prospective roles of magnetic resonance imaging in mild traumatic brain injury
Sassani M. et al, (2025), Brain Communications, 7